Stockholm3 Validation Study in a Multi-Ethnic Cohort

CompletedOBSERVATIONAL
Enrollment

2,152

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions
Prostate Cancer (Diagnosis)
Interventions
DIAGNOSTIC_TEST

The Stockholm3 test

Venipuncture: Prior to the biopsy the blood will be collected in 2 EDTA (lavender top) x 4 ml tubes will be removed after obtaining consent from the subjects.

Trial Locations (14)

10467

Montefiore Medical Center, The Bronx

60154

Uropartners, Westchester

60611

Northwestern Medicine, Chicago

60612

John H. Stroger, Jr. Hospital of Cook County, Chicago

Rush University Medical Center, Chicago

University of Illinois at Chicago, Chicago

60615

Cook County Health System, Chicago

60637

University of Chicago, Chicago

75231

Urology Clinics of North Texas, Dallas

78229

University of Texas Health Science Center San Antonio, San Antonio

90033

Los Angeles County, Los Angeles

University of Southern California, Los Angeles

94304

Stanford University, Palo Alto

Unknown

University Health Network, Toronto

All Listed Sponsors
collaborator

University of Illinois at Chicago

OTHER

collaborator

UroPartners

UNKNOWN

collaborator

University of Chicago

OTHER

collaborator

Rush University Medical Center

OTHER

collaborator

Montefiore Medical Center

OTHER

collaborator

The University of Texas Health Science Center at San Antonio

OTHER

collaborator

Cook County Health & Hospitals System

OTHER

collaborator

Cook County Health

OTHER_GOV

collaborator

Stanford University

OTHER

collaborator

Northwestern Medicine

OTHER

collaborator

University of Southern California

OTHER

collaborator

University Health Network, Toronto

OTHER

collaborator

Urology Clinics of North Texas

NETWORK

collaborator

LAC+USC Medical Center

OTHER

lead

Karolinska Institutet

OTHER

NCT04583072 - Stockholm3 Validation Study in a Multi-Ethnic Cohort | Biotech Hunter | Biotech Hunter